155 related articles for article (PubMed ID: 5585384)
1. [. 663 (G 30320 "Geigy"), a new chemotherapeutic agent against leprosy].
Vischer WA
Schweiz Med Wochenschr; 1967 Mar; 97(10):308. PubMed ID: 5585384
[No Abstract] [Full Text] [Related]
2. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.
Pettit JH; Rees RJ; Ridley DS
Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368
[No Abstract] [Full Text] [Related]
3. Antibacterial effects of G 30'320 Geigy (B663) in lepromatous leprosy.
Hastings RC; Trautman JR; Mansfield RE
Dermatol Int; 1969; 8(1):21-7. PubMed ID: 5343403
[No Abstract] [Full Text] [Related]
4. Forty-four months' experience in the treatment of leprosy with clofazimine (Lamprene (Geigy)).
Schulz EJ
Lepr Rev; 1971 Sep; 42(3):178-87. PubMed ID: 5151819
[No Abstract] [Full Text] [Related]
5. The treatment of erythema nodosum leprosum with B.663. A controlled study.
Pettit JH
Int J Lepr Other Mycobact Dis; 1967; 35(1):11-6. PubMed ID: 4290017
[No Abstract] [Full Text] [Related]
6. Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report.
Tolentino JG; Rodriquez JN; Abalos RM
Int J Lepr Other Mycobact Dis; 1971; 39(3):738-41. PubMed ID: 5169924
[No Abstract] [Full Text] [Related]
7. Studies on sulfone resistance in leprosy. 3. A case of "partial" resistance.
Pearson JM; Pettit JH; Rees RJ
Int J Lepr Other Mycobact Dis; 1968; 36(2):171-8. PubMed ID: 4877115
[No Abstract] [Full Text] [Related]
8. Drugs for leprosy.
Rees RJ
Trop Doct; 1973 Apr; 3(2):92-5. PubMed ID: 4691437
[No Abstract] [Full Text] [Related]
9. Clofazimine in leprosy.
Browne SG
Br Med J; 1972 Feb; 1(5798):506-7. PubMed ID: 4550304
[No Abstract] [Full Text] [Related]
10. Clofazimine (B663, Geigy) in leprosy reactions.
Smith RB
Australas J Dermatol; 1972 Apr; 13(1):31-5. PubMed ID: 5082494
[No Abstract] [Full Text] [Related]
11. Story behind the clinical trial of B.663 in leprosy.
Chang YT
Int J Lepr Other Mycobact Dis; 1967; 35(1):78-80. PubMed ID: 6067040
[No Abstract] [Full Text] [Related]
12. The evaluation of present antileprosy compounds.
Browne SG
Adv Pharmacol Chemother; 1969; 7():211-51. PubMed ID: 4910168
[No Abstract] [Full Text] [Related]
13. Leprosy research at the National Institutes of Health: experience with B.663 in the treatment of leprosy.
Williams TW; Mott PD; Wertlake PT; Rubio JB; Adler RC; Hill GJ; Suarez GP; Knight V
Int J Lepr; 1965; 33(3):Suppl:767-77. PubMed ID: 5322715
[No Abstract] [Full Text] [Related]
14. Controlled clinical trial of clofazimine in untreated lepromatous leprosy.
Karat AB; Jeevaratnam A; Karat S; Rao PS
Br Med J; 1971 Nov; 4(5786):514-6. PubMed ID: 4942741
[TBL] [Abstract][Full Text] [Related]
15. A new analogous model for the detection and evaluation of chemotherapeutic products effective in leprosy.
Freerksen E; Rosenfeld M
Arzneimittelforschung; 1972 Aug; 22(8):1235-42. PubMed ID: 4678384
[No Abstract] [Full Text] [Related]
16. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
Waters MF; Rees RJ; Sutherland I
Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
[No Abstract] [Full Text] [Related]
17. New drug for leprosy.
Br Med J; 1969 Mar; 1(5647):797-8. PubMed ID: 5774074
[No Abstract] [Full Text] [Related]
18. G 30 320 or B 663--lampren (Geigy).
Waters MF
Lepr Rev; 1969 Jan; 40(1):21-47. PubMed ID: 4888382
[No Abstract] [Full Text] [Related]
19. Treatment of leprosy with Lampren (B.663 Geigy).
De las Aguas JT
Int J Lepr Other Mycobact Dis; 1971; 39(2):493-503. PubMed ID: 4948089
[No Abstract] [Full Text] [Related]
20. Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy.
Karat AB; Jeevaratnam A; Karat S; Rao PS
Int J Lepr Other Mycobact Dis; 1971; 39(4):838-41. PubMed ID: 5170472
[No Abstract] [Full Text] [Related]
[Next] [New Search]